G
G. Dobrilla
Publications - 29
Citations - 650
G. Dobrilla is an academic researcher. The author has contributed to research in topics: Ranitidine & Placebo. The author has an hindex of 12, co-authored 29 publications receiving 642 citations.
Papers
More filters
Journal ArticleDOI
Oral Cromolyn Sodium in Comparison with Elimination Diet in the Irritable Bowel Syndrome, Diarrheic Type Multicenter Study of 428 Patients
Giuseppe Francesco Stefanini,A. Saggioro,V. Alvisi,Giampaolo Angelini,L. Capurso,G. Di Lorenzo,G. Dobrilla,M. Dodero,M. Galimberti,G. Gasbarrini,O. Manghisi,L. Marsigli,G. Mazzacca,L. Rigo,G. Sacerdoti,R. Scolozzi,C. Surrenti,I. Grazioli,G. Melzi +18 more
TL;DR: These results confirm the high prevalence of adverse reactions to foods in diarrheic irritable bowel syndrome and the usefulness of cromolyn sodium treatment in these patients.
Journal ArticleDOI
Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials.
TL;DR: The pooled estimate provides evidence of the short-term efficacy of both the antisecretory and gastrokinetic agents, whether considered as drug classes or as individual drugs, and confirms the importance of the placebo effect in FD.
Journal ArticleDOI
Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy - A randomized clinical study
Francesco Orlandi,Umberto Freddara,Maria Teresa Candelaresi,Antonio Morettini,Gino Roberto Corazza,Aurelio Di Simone,G. Dobrilla,Giorgio Cavallini +7 more
TL;DR: This first large-scale investigation on hepatic encephalopathy demonstrated a similar effectiveness of the two drugs in grade 1 encephalopathic syndrome and provides a basis for drug selection in the current management of the syndrome.
Journal ArticleDOI
Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial.
F. Baldi,G. Bianchi Porro,G. Dobrilla,C. Iascone,R. Lobello,L. Marzio,F. Sabbatini,A. Tittobello,Giorgio Verme +8 more
TL;DR: Results show that cisapride, 10 mg q.i.d., heals esophagitis lesions and greatly reduces associated symptoms and the treatment was well tolerated.
Journal ArticleDOI
Circulating trypsin-like immunoreactivity in chronic pancreatitis.
Angelo Andriulli,G. Masoero,M. Felder,Italo Vantini,M. Petrillo,Giorgio Cavallini,G. Bianchi Porro,G. Dobrilla,Giorgio Verme +8 more
TL;DR: The finding of low levels also in a minority of chronic pancreatitis patients with normal endoscopic retrograde cholangiopancreatography or pancreatic secretory tests points to other factors which, in addition to the atrophy of the pancreatic parenchyma, may influence the circulating levels of trypsin-like immunoreactivity in Chronic pancreatitis.